28.04.2021 12:20:05
|
Integra LifeSciences Q1 Profit Tops Estimates
(RTTNews) - Integra LifeSciences Holdings Corp. (IART) reported first quarter adjusted earnings per share of $0.69, compared to $0.48, prior year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items.
The company reported GAAP net income of $45.4 million, or $0.53 per share, compared to $9.2 million, or $0.11 per share, last year.
Reported revenues were $360.1 million, an increase of 1.6% on a reported basis and an increase of 2.9% on an organic basis compared to the prior year. Analysts expected revenue of $349.81 million, for the quarter.
For the second quarter, the company expects revenues to be in a range of $372 million to $378 million, representing reported growth of approximately 44% to 46% and organic growth of 42% to 44%. Adjusted earnings per share are expected to be in a range of $0.63 to $0.67.
The company increased the lower end of its full-year 2021 revenue guidance by $5 million to a revised range of $1.525 billion to $1.535 billion, representing reported growth of 11% to 12% and organic growth of 12% to 13%. The company now projects towards the higher end of its full-year 2021 adjusted earnings per share guidance range of $2.86 to $2.93.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Integra LifeSciences Holdings Corp.mehr Nachrichten
03.03.25 |
NASDAQ Composite Index-Papier Integra LifeSciences-Aktie: So viel Verlust hätte eine Investition in Integra LifeSciences von vor einem Jahr bedeutet (finanzen.at) | |
25.02.25 |
NASDAQ Composite aktuell: NASDAQ Composite verbucht zum Ende des Dienstagshandels Verluste (finanzen.at) | |
25.02.25 |
Angespannte Stimmung in New York: NASDAQ Composite im Minus (finanzen.at) | |
25.02.25 |
Börse New York: NASDAQ Composite notiert am Mittag im Minus (finanzen.at) | |
25.02.25 |
Schwache Performance in New York: NASDAQ Composite beginnt Dienstagshandel in der Verlustzone (finanzen.at) | |
24.02.25 |
Verluste in New York: NASDAQ Composite schließt im Minus (finanzen.at) | |
24.02.25 |
NASDAQ Composite Index-Titel Integra LifeSciences-Aktie: So viel hätten Anleger mit einem Investment in Integra LifeSciences von vor 10 Jahren verloren (finanzen.at) | |
24.02.25 |
Ausblick: Integra LifeSciences legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) |
Analysen zu Integra LifeSciences Holdings Corp.mehr Analysen
Aktien in diesem Artikel
Integra LifeSciences Holdings Corp. | 20,20 | 0,00% |
|